Disclosure Under Scrutiny: Were PayPal's Risk Warnings Adequate While Known Problems Went Undisclosed?
Levi & Korsinsky, LLP examines the adequacy of PayPal Holdings, Inc.'s (NASDAQ: PYPL) risk disclosures during the period February 25, 2025, through February 2, 2026. A securities class action has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased PYPL stock during that period and lost money. Find out if you are entitled to recover investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
PayPal shares fell $10.63 per share, a decline of 20.31%, on February 3, 2026, after the Company withdrew its 2027 financial targets and disclosed "operational and deployment issues" across all regions alongside the abrupt termination of its CEO.
What the Company Disclosed
Throughout the Class Period, PayPal's SEC filings contained standard risk factor language acknowledging general competitive pressures and the possibility that growth initiatives might not succeed as planned. The Company's Analyst/Investor Day presentation on February 25, 2025, and subsequent earnings calls projected confidence in specific, quantified targets: 8% to 10% TPV growth by 2027, more than 80% global coverage of new checkout experiences, and 7% to 9% transaction margin dollar growth.
What the Complaint Alleges Was Missing
The securities action contends that while PayPal offered boilerplate risk disclosures, the Company simultaneously withheld specific, known problems that were already undermining those projections:
- PayPal's salesforce was allegedly not equipped to execute on the growth targets management presented to investors
- Management was allegedly "too optimistic" about how easily and quickly staff could change customer adoption patterns
- Operational and deployment problems existed across all regions, not just isolated markets, as alleged in the complaint
- The gap between projected branded checkout acceleration and actual internal readiness was allegedly known to senior executives who signed SEC certifications
- Competitive pressures and macroeconomic headwinds were allegedly more severe than generic risk factors suggested
Regulatory Reality
The complaint challenges the adequacy of PayPal's disclosures under Section 10(b) of the Securities Exchange Act and SEC Rule 10b-5. These provisions require companies to ensure that when they choose to speak on a topic, they do so completely and without material omission. The action asserts that PayPal's decision to provide specific 2027 financial targets created an obligation to disclose known internal barriers to achieving those targets.
Why Generic Warnings May Not Protect
The filing states that generalized risk factor language warning that "growth initiatives may not succeed" is insufficient when a company possesses specific knowledge that its workforce cannot execute the plan being pitched to investors. As alleged, PayPal's February 2025 Analyst Day projections were not aspirational goals hedged by adequate warnings. They were presented as concrete, measurable targets backed by "rigorous" plans, even as the internal reality allegedly contradicted them.
"Generic risk factor language cannot substitute for disclosing specific, known problems that are already affecting a company's operations. When a company provides investors with detailed financial targets, adequate disclosure requires candor about internal obstacles to meeting those targets." -- Joseph E. Levi, Esq.
Request a free evaluation of your PYPL losses or call (212) 363-7500.
LEAD PLAINTIFF DEADLINE: April 20, 2026
Levi & Korsinsky, LLP, Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered for investors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260310646903/en/
Contacts
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
